Antioxidant/Cancer Disease Claims Prompt FDA Letters
This article was originally published in The Tan Sheet
Executive Summary
Cancer claims for Chemron's Sun Ginseng are misbranded due to labeling shortcomings, FDA says in a recent courtesy letter to the company